Ionsys
Generic name: fentanyl
Treatment for: Pain
ALZA Corporation Receives Approvable Letter Regarding IONSYS, an Iontophoretic, Fentanyl-containing, Transdermal Analgesic
MOUNTAIN VIEW, Calif., July 27, 2004 -- ALZA Corporation today announced it has received an approvable letter from the U.S. Food and Drug Administration (FDA) regarding a New Drug Application (NDA) for IONSYS.
ALZA submitted a NDA for IONSYS in September 2003. It is working with the FDA to address the agency's letter as quickly as possible.
ALZA Corporation, a member of the Johnson & Johnson family of companies, is a leading developer of drug delivery-based pharmaceutical products.
Posted: July 2004
Related articles
- ALZA Corporation Resubmits U.S. New Drug Application for IONSYS (Fentanyl HCl Patient-Activated Transdermal System) - November 28, 2005
Ionsys (fentanyl) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
